BLFS · As filed with the SEC
Biolife Solutions balance sheet, by fiscal year
The statement as Biolife Solutions presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 | FY2020 Dec 31, 2020 | FY2019 Dec 31, 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | 33,038 | 95,386 | 35,407 | 19,442 | 69,860 | 90,403 | 6,448 |
| Restricted cash | — | — | 31 | 31 | 10 | 53 | 0 |
| Available-for-sale securities, current portion | 55,889 | 9,198 | 16,288 | 43,260 | — | — | — |
| Accounts receivable, trade, net of allowance for credit losses of $22 and $152 as of December 31, 2025 and December 31, 2024, respectively | 7,953 | 9,168 | 18,657 | 33,936 | 23,217 | 8,006 | 5,345 |
| Inventories | 30,155 | 29,013 | 43,456 | 34,904 | 28,345 | 11,602 | 10,972 |
| Prepaid expenses and other current assets | 9,526 | 5,996 | 6,765 | 6,879 | 4,427 | 4,648 | 1,348 |
| Current assets, discontinued operations | 0 | 0 | — | — | — | — | — |
| Total current assets | 136,561 | 148,761 | 120,604 | 138,452 | 125,859 | 114,712 | 24,113 |
| Assets held for rent, net | — | — | — | 9,064 | 9,809 | 4,705 | 3,922 |
| Assets held for rent, net | — | 6,103 | 7,713 | — | — | — | — |
| Property and equipment, net | 14,713 | 6,084 | 21,077 | 23,638 | 17,657 | 10,120 | 5,572 |
| Operating lease right-of-use assets, net | 7,466 | 10,674 | 11,446 | 15,292 | 18,705 | 9,675 | 1,040 |
| Financing lease right-of-use assets, net | — | — | 94 | 272 | 440 | 17 | 0 |
| Long-term deposits and other assets | — | 379 | 273 | 281 | 325 | 230 | 50 |
| Other assets | 3,050 | — | — | — | — | — | — |
| Available-for-sale securities, long term | 31,250 | 4,628 | 548 | 1,332 | — | — | — |
| Equity Investments | — | — | — | 5,069 | 4,372 | 5,872 | 2,500 |
| Equity Investments | — | — | 5,069 | — | — | — | — |
| Equity investments | 0 | 995 | — | — | — | — | — |
| Intangible assets, net | 4,257 | 9,559 | 21,149 | 32,088 | 152,149 | 31,049 | 21,982 |
| Goodwill | 208,587 | 212,304 | 224,741 | 224,741 | 224,741 | 58,449 | 33,637 |
| Long-term assets, discontinued operations | 0 | 0 | — | — | — | — | — |
| Total assets | 405,884 | 399,487 | 412,714 | 450,229 | 554,057 | 234,829 | 92,816 |
| Liabilities and Shareholders’ Equity | |||||||
| Current liabilities: | |||||||
| Accounts payable | 1,486 | 3,573 | 6,940 | 15,367 | 14,945 | 3,672 | 3,119 |
| Accrued expenses and other current liabilities | 11,974 | 12,451 | 11,932 | 9,782 | 7,142 | 5,369 | 3,369 |
| Sales taxes payable | 2,279 | 4,256 | 5,442 | 4,151 | — | — | — |
| Warranty liability | — | — | 7,858 | 8,312 | 9,398 | — | — |
| Lease liabilities, operating, current portion | 2,243 | 1,511 | 2,797 | 2,860 | 2,758 | 1,107 | 804 |
| Lease liabilities, financing, current portion | — | — | 376 | 158 | 149 | 8 | 0 |
| Debt, current portion | 4,997 | 10,943 | 6,833 | 1,814 | 862 | — | — |
| Warrant liability | — | — | — | — | 0 | 2,780 | 0 |
| Contingent consideration, current portion | — | — | 0 | 2,138 | 5,127 | 2,637 | 377 |
| Current liabilities, discontinued operations | 0 | 0 | — | — | — | — | — |
| Total current liabilities | 22,979 | 32,734 | 42,178 | 44,582 | 40,381 | 15,573 | 7,669 |
| Warrant liability, long-term | — | — | — | — | — | 0 | 39,602 |
| Contingent consideration, long-term | — | — | 0 | 2,318 | 4,900 | 4,515 | 1,537 |
| Lease liabilities, operating, long-term | 10,657 | 12,723 | 13,205 | 14,962 | 16,466 | 8,757 | 550 |
| Lease liabilities, financing, long-term | — | — | 1,169 | 126 | 291 | 12 | 0 |
| Debt, long-term | 0 | 4,997 | 18,311 | 23,793 | 6,353 | — | — |
| Deferred tax liabilities | 189 | 124 | 188 | 250 | 5,487 | — | — |
| Other long-term liabilities | 171 | — | 0 | 10 | 42 | 726 | 4 |
| Long-term liabilities, discontinued operations | 0 | 0 | — | — | — | — | — |
| Total liabilities | 33,996 | 50,578 | 75,051 | 86,041 | 73,920 | 29,583 | 49,362 |
| Shareholders’ equity: | |||||||
| Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common stock, $0.001 par value; 150,000,000 shares authorized, 48,198,928 and 46,906,765 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 48 | 47 | 45 | 43 | 42 | 33 | 21 |
| Additional paid-in capital | 711,404 | 683,939 | 651,305 | 611,739 | 585,397 | 302,598 | 143,485 |
| Accumulated other comprehensive loss, net of taxes | 132 | 24 | (345) | (679) | (282) | — | — |
| Accumulated deficit | (339,696) | (335,101) | (313,342) | (246,915) | (105,020) | (97,385) | (100,052) |
| Total shareholders’ equity | 371,888 | 348,909 | 337,663 | 364,188 | 480,137 | 205,246 | 43,454 |
| Total liabilities and shareholders’ equity | 405,884 | 399,487 | 412,714 | 450,229 | 554,057 | 234,829 | 92,816 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.